Florian Naudet
A training curriculum for clinical trial data sharing
Data sharing is a complex endeavor that maximizes the value of clinical research. In a recent piece, we argue that more biomedical...
top of page
Rechercher
Florian Naudet
13 déc. 20222 min de lecture
"There’s nothing in headache medicine that can really do that" Really?
With a group of independent experts, we were very surprised to see that the scientific journal Nature published a series of 12 news...
57 vues0 commentaire
Florian Naudet
20 sept. 20224 min de lecture
Exploring Vibration of Effects in Pooled Analyses
Pooled analyses (ie, non-exhaustive quantitative syntheses that pool individual participant data from several independent RCTs exploring...
38 vues0 commentaire
Florian Naudet
24 mai 20224 min de lecture
Feedback on the process of our first registered report
"Registered Reports is a publishing format that emphasizes the importance of the research question and the quality of methodology by...
41 vues0 commentaire
Florian Naudet
21 mai 20223 min de lecture
Data-sharing and re-analysis for main studies assessed by the EMA: our first registered report!
We have just published our first registered report in BMC Medicine. Let's celebrate ! Transparency and reproducibility are expected to be...
151 vues0 commentaire
Florian Naudet
15 nov. 20211 min de lecture
Registered report / in principle acceptance: esketamine for “treatment resistant depression"
Our new registered report "Efficacy and safety of esketamine for “treatment resistant depression”: registered report for a Systematic...
179 vues0 commentaire
Florian Naudet
22 août 20212 min de lecture
Studying the impact of data sharing initiatives
In our new scoping review, we explored the impact of clinical trial data-sharing initiatives. We looked at various outcome domains...
53 vues0 commentaire
Florian Naudet
9 août 20212 min de lecture
An open science pathway for drug marketing authorization
Our essay "An open science pathway for drug marketing authorization -Registered drug approval" won the "Reimagine Biomedical Research for...
33 vues0 commentaire
Florian Naudet
25 mai 20213 min de lecture
Concerns about the Sputnik V phase 3 trial
In a recent letter, as part of an international group (Enrico Bucci, Johannes Berkhof, André Gillibert, Gowri Gopalakrishna, Raffaele A...
691 vues0 commentaire
Florian Naudet
30 avr. 20211 min de lecture
Sharing of Clinical Trial Data - 2nd Workshop - Recordings
On April 1st, 2021, our group and colleagues from the Ludwig-Maximilians-Universität München (Faculty of Medicine) organized a workshop...
68 vues0 commentaire
Florian Naudet
27 mars 20215 min de lecture
Conflicts of interests in research
We have just registered our new protocol on the Open Science Framework. We are planning a new study about conflict of interests in...
111 vues0 commentaire
Florian Naudet
24 mars 20212 min de lecture
Sharing of Clinical Trial Data - 2nd Workshop 1.04.2021
Again some good news! On April the 1st this year, our group and colleagues from the Ludwig-Maximilians-Universität München (Faculty of...
226 vues0 commentaire
Florian Naudet
7 janv. 20211 min de lecture
Sharing of Clinical Trial Data - Workshop 19.01.2021
Finally some good news in 2021 ! On January 19th this year, our group and colleagues from the Ludwig-Maximilians-Universität München...
241 vues0 commentaire
fabiola gaba
20 août 20201 min de lecture
Funders' data sharing policies in therapeutic research
“Funders’ data-sharing policies in therapeutic research: a survey of commercial and non-commercial funders” is the new article, from the...
54 vues0 commentaire
Florian Naudet
7 août 20203 min de lecture
Artemisia infusions: correcting the records was difficult
This story is about Artemisia and two very "interesting" (or should I say infamous) studies. 1/ Well, read this paper: "Artemisia annua...
785 vues0 commentaire
Florian Naudet
25 juin 202014 min de lecture
Proposal for improved reporting of the RECOVERY trial
Taking advantage of the many good things pre print servers offer, and in a spirit of open science, we wrote a peer review with Andre...
164 vues0 commentaire
Max
31 mai 20201 min de lecture
An Audit of journals following the ICMJE recommendations
"Data-sharing recommendations in biomedical journals and Randomized Controlled Trials: an audit of journals following the ICMJE...
47 vues0 commentaire
Florian Naudet
5 mai 20204 min de lecture
The BACLOVILLE study and the long road to transparency
We hypothesize in our projects that re-analyses of a random sample of unselected Randomised Controlled Trials will result in a good...
94 vues0 commentaire
Max
10 avr. 20202 min de lecture
ReiTheR goes Berlin
In mid-february our team made its way to the 3 day REWARD EQUATOR conference, which was hosted by the BIH Quest Center in Berlin,...
56 vues0 commentaire
Florian Naudet
8 avr. 20201 min de lecture
EMA monitor
Our new paper, "The evidence base for psychotropic drugs approved by the European Medicines Agency [EMA]: a meta-assessment of all...
80 vues0 commentaire
Blog: Blog2
bottom of page